Compare AVXL & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVXL | DDD |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.6M | 373.9M |
| IPO Year | N/A | N/A |
| Metric | AVXL | DDD |
|---|---|---|
| Price | $5.18 | $2.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $22.00 | $4.75 |
| AVG Volume (30 Days) | 2.1M | ★ 4.6M |
| Earning Date | 02-11-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $391,651,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.31 |
| P/E Ratio | ★ N/A | $25.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.86 | $1.32 |
| 52 Week High | $13.99 | $5.00 |
| Indicator | AVXL | DDD |
|---|---|---|
| Relative Strength Index (RSI) | 69.64 | 68.23 |
| Support Level | $4.67 | $2.26 |
| Resistance Level | $4.44 | $2.72 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | 0.19 | 0.09 |
| Stochastic Oscillator | 96.45 | 98.01 |
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.